Skip to main content
argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
697.42
+72.12 (11.53%)
At close: Jan 29, 2025

argenx SE Revenue

In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth. argenx SE had revenue of $757.39M in the quarter ending December 31, 2024, with 81.26% growth.

Revenue
2.25B
Revenue Growth
+77.22%
P/S Ratio
16.54
Revenue / Employee
1.41M
Employees
1,599
Market Cap
37.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.25B979.61M77.22%
Dec 31, 20231.27B827.58M187.66%
Dec 31, 2022441.01M-87.25M-16.52%
Dec 31, 2021528.27M466.31M752.59%
Dec 31, 202061.96M-30.85M-33.24%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Silence Therapeutics 43.26M
Revenue Rankings

argenx SE News

More News